home . 2007 news
 

Recent News

     Encysive : Encysive Pharmaceuticals Announces Patent Infringement Lawsuit Against Barr Laboratories

     Encysive : Encysive Pharmaceuticals Receives Delisting Warning Letter From NASDAQ

     Encysive : Encysive Pharmaceuticals Provides THELIN Sales Guidance for 2007 and 2008

     XTL Bio : XTL Presents Data Regarding its Hepatitis C Virus Small Molecule Program

     ET Water : ET Water Signs Letter of Intent To Emerge From Bankruptcy

     Promia : University Bank Buys New Promia Raven Product

     Encysive : Encysive Pharmaceuticals Launches Thelin (sitaxentan sodium) in Italy

     Encysive : Encysive Presents Sitaxsentan Data in Eisenmenger Syndrome at AHA Meeting

     Encysive : Encysive Pharmaceuticals Reports Third Quarter 2007 Financial Results

     XTL Bio : XTL Announces Delisting from the Official List of the United Kingdom Listing Authority

     Encysive : Encysive Pharmaceuticals to Present At the Acumen BioFin Rodman and Renshaw Healthcare Conference

     XTL Bio : XTL Biopharmaceuticals to Present at the Rodman & Renshaw 9th Annual Health Care Conference

     XTL Bio : XTL Biopharmaceuticals to Present at the Rodman & Renshaw 9th Annual Health Care Conference

     XTL Bio : XTL Biopharmaceuticals Ltd. Announces $9.6 Million Private Placement to Institutional Investors

     Encysive : Encysive Pharmaceuticals Announces Long-Term Study of Sitaxsentan Presented At Chest Meeting

     NuVision : NuVision® Files Lawsuit Against Panasonic for Trademark Infringement

     NuVision : NuVision® Taps Bill Muster as Director of Product Marketing

     XTL Bio : AGM / EGM STATEMENTS

     XTL Bio : XTL to Appeal NASDAQ Staff Determination

     XTL Bio : XTL AGM / EGM Postponed Until October 2, 2007

     XTL Bio : XTL Presents a New Class of Highly Potent Small Molecule Inhibitors of Hepatitis C

     Summit Communications, LLC : Summit Publishes Concise and Timely Monograph in Spine Surgery

     XTL Bio : XTL to Discuss the Phase IIb Clinical Trial of Bicifadine

     XTL Bio : XTL: Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain

     XTL Bio : XTL Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C

     XTL Bio : XTL Biopharmaceuticals to Present at the Arch Investment Conference

     XTL Bio : XTL Receives Staff Letter from NASDAQ

     Promia : Promia RavenTM Network Security Appliances Now Shipping

     XTL Bio : XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007

     XTL Bio : Annual General Meeting Notices Posted to Shareholders

     XTL Bio : XTL Biopharmaceiticals Announces Financial Results

     NuVision : NuVision Introduces 10 New Lucidium Series 1080p Deep Black LCD Flat Panels, From 22- to 65-Inches

     NuVision : NuVision Launches Plug ‘n’ Play Control

     NuVision : Sound And Vision Magazine Impressed with 52" 1080p LED Illuminated DLP HDTV by NuVision

     NuVision : New York City’s Trump Corporation Utilizes Custom NuVision LCD TVs for Brokerage Storefront Window

     NuVision : NuVision Names Mike Aiken Director of Product Development

     ET Water : ET Water Appoints William Hasler and Peter Dalton to Board of Directors

     XTL Bio : XTL Provides Update on Phase I Clinical Trial of XTL-2125

     Summit Communications, LLC : Summit Publishes Definitive Blood and Marrow Transplantation Manual

     Promia : SRI International and Promia Extend Cyber Threat Analysis Agreement for the US Army

     NuVision : NYSS Home Theater Joins NuVision Dealer Network

     ET Water : Water systems startup sees flood of sales

     XTL Bio : XTL to Present at the Acumen BioFin Rodman & Renshaw Conference

     NuVision : HomeToys Rates NuVision Superior and Best In Class

     NuVision : Home Entertainment Magazine Raves About NuVision

     XTL Bio : XTL Announces the Completion of Phase I Study with XTL-6865 in Patients with Chronic Hepatitis C

     ET Water : ET Water Introduces New Flow Monitoring and Control Features

     XTL Bio : XTL Biopharmaceuticals Announces Financial Results

     ET Water : State of the Art Technologies Converge

     XTL Bio : XTL to Present at Oppenheimer’s Conference

     Promia : Promia's Intelligent Agent Security Manager Provides Navy Enterprise-Wide Security Risk Awareness

     XTL Bio : XTL Biopharmaceuticals to Present at the 9th Annual BIO CEO & Investor Conference

     XTL Bio : XTL Announces the In-Licensing of Bicifadine a Late-Stage Clinical Compound

     ET Water : ET Water Wins Prestigious Wall Street Journal Technology Innovation Award

     Dekker Foundation : John J. McKetta Undergraduate Scholarship

     XTL Bio : XTL Biopharmaceuticals to Present at the 25th Annual JPMorgan Healthcare Conference

     ET Water : Technology Innovation Winners 2006

     Promia : Promia Signs Trusted Technologies as Sales Partner for the Intelligent Agent Security Manager Line

     Promia : SRI International and Promia Sign Research Agreement for Cyber Threat Analysis for the U.S. Army